Condition 1: Sexual Dysfunction. Condition 2: Type 2 Diabetes. Sexual dysfunction not due to a substance or known physiological condition Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: Weekly prescription of Pearl Vitamin D with a dose of 50,000 made by Tehran Daru Company for 12 weeks after lunch to increase drug absorption. Intervention 2: Contr
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: Married women between 18 to 49 years old Not suffering from a wide range of diseases that lead to sexual dysfunction Including: multiple sclerosis and any central nervous system disorders, mental disorders, mental retardation, vasculitis, uncontrolled hypo and hyperthyroidism, anatomical defects of the reproductive system, tumors and tumors and cancer Not taking drugs affecting sexual function Including: H2 receptor blockers, sleeping pills, cardiac and antihypertensive drugs, anticonvulsants, narcotic drugs, anticancer drugs and corticosteroids, antihistamines, opioids and alcohol and psychotropic drugs, barbiturates Gynecologic health and absence of endometriosis Absence of erectile disorders in the husband Minimum literacy level of the participants Self-reported absence of alcohol and smoking addiction by the women Awareness of place and time Satisfaction and willingness to participate in research suffering from Type 2 diabetes for at least one year Not taking vitamin D supplements at least three months before entering the study Have normal levels of serum Calcium, Phosphorus, and Albumin Body mass index (BMI) should be less than 30 Absence of malabsorption disorders Having insufficient vitamin D level (10 – 30 ng/ml)
Exclusion criteria
Exclusion criteria: Being pregnant or in the the firs trimester after delivery Surgical history of oophorectomy, hysterectomy, and mastectomy Early menopause (age less than 40 years)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before the intervention and 13 weeks after the intervention. Method of measurement: Female Sexual Function Index Questionnaire (FSFI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Vitamin D serum level. Timepoint: Before intervention. Method of measurement: HPLC kit (high performance liquid chromatography.;Depression score. Timepoint: Before intervention. Method of measurement: DASS21 questionnaire score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Shakouri Jobani
Esfahan University of Medical Sciences
Outcome results
None listed